ON
🔍
← Back to feed
United StatesBusiness5 days ago

STAT+: How a biotech turned a trial failure into an AI model

The article discusses how a biotechnology company transformed a failed trial into an AI model, though the full details of the story are behind a paywall and not accessible in the provided text.

You’re reading the web edition of STAT Health Tech

Adobe

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter . You can reach Mario on Signal at mariojoze.13.

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday.

Good morning health tech readers!

Think anyone will notice if I sneak out to go to a parade in New York on Thursday?

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Health Tech Correspondent

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter . You can reach Mario on Signal at mariojoze.13.

Read the full article at STAT News →

1 reports

STAT NewsIndependentCenter5 days ago
STAT+: How a biotech turned a trial failure into an AI model

The article discusses how a biotechnology company transformed a failed trial into an AI model, though the full details of the story are behind a paywall and not accessible in the provided text.

Bias read (Center): The subject matter focuses on business and technology within the healthcare sector, which is not inherently politically charged. The article does not present any clear ideological framing or bias in its summary.